Hospital Medicine

New data show patients who receive referred specialist care from a physician who went to medical school or other certification programs with their primary provider report better survey scores.

The primary outcome was the number of days alive and out of the hospital at 90 days after trial initiation.

Qualitative interview analysis show male department chairs commonly witness discrimination against their female peers—yet they often are silent for a litany of reasons.

From a topical gene therapy to a debated heart failure option, a litany of unique agents are anticipated for FDA decision in the new year.

Why has this season brought an unprecedented number of severe RSV infections, and why is vaccine development taking so long?

New longitudinal data support bolstered use of booster doses among health care workers in US nursing homes.

"The challenge right now is that we have no therapies in the emergency department to treat acute pain, outside of pain medications and IV opioids," Dr. Claudia Morris says in an interview.

This novel concept can benefit patients and clinicians alike by appropriately applying new technologies to identify bacteria more efficiently and decrease the time to optimal therapy.

The FDA's plans to expedite and expand regulatory pathways has resulted in a novel drug development boom since 2017. The commissioner discusses the details of their strategy.

The indication makes tocilizumab the first monoclonal antibody to be granted full FDA approval to treat the pandemic virus.

As we begin our annual health care recap series this month, let's take a look back at the stories our readers liked most.

The findings indicate a discrepancy between racial and ethnic demographic data in RCTs of DME and RVO and the 2010 US Census population.

Study data show 64.3% of patients self-administering etripamil converted to sinus rhythm within 30 minutes compared to 31.2% on placebo.

New data indicate a statistically not significant increase in the rate of treatment for PH, but investigators stress its potential clinical importance.

A study from the Netherlands suggests steps to address patients’ sleep health.

Diabetes mortality rates in 2017-2018 compared with 1999-2000 were highest and unchanged in rural counties.

The approval is based on data from 2 clinical trials showing the agent improved the rate of post-operation patients avoiding sickness by 50%.

Children identifying as Black, Mexican American, low-income, or non-US citizen were more likely to report poor subjective visual function from 2005 to 2008.

Individuals who reported three cumulative insomnia symptoms of DIS, DSM and NRS had 40% increased risk of future bloodstream infection.

A research letter by Emory University investigators found racial disparities in temperature measurements for Black and White hospital patients.

Macular atrophy and hyperreflective material were common after 7 years of follow-up in IVAN trial.

Lower prescriptions for racial, ethnic groups relative to White, non-Hispanic patients remained after accounting for patient- and system-level characteristics.

The investigators found no significant differences when trainees participated in the ADR, CIR, and perforation rate compared to when trainees did not participate.

An increasing retinal nonperfusion index was associated with a significantly higher risk of Diabetic Retinopathy Severity Scale worsening.

26 weeks of treatment with empagliflozin reduced the myocardial glucose metabolic rate by 45.1% in patients with type 2 diabetes.